eLife · 2022
Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Giulieri Stefano G, Guérillot Romain, Duchene Sebastian, Hachani Abderrahman, Daniel Diane, Seemann Torsten, Davis Joshua S, Tong Steven Y C, Young Bernadette C, Wilson Daniel J, Stinear Timothy P, Howden Benjamin P
Аннотация
BACKGROUND: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with a poor prognosis in advanced stages. Although histological tumor grading is an established prognostic parameter, it often fails to capture the biological heterogeneity of RCC. Therefore, identifying novel biomarkers could enhance early diagnosis and improve predictive accuracy. Here, we aimed to test whether immunophenotypes of specific glutathione peroxidase (GPX) family members may have prognostic value in RCC.
METHODS: We investigated the relationship between GPX1 and GPX3 immunophenotypes and clinicopathological parameters in 32 surgical specimens of clear cell RCC (ccRCC) with nucleolar grade 1-4 (WHO/ISUP grading). We evaluated the GPX1 and GPX3 immunophenotypes and assigned a histological immunoscore for each marker. For analysis, we used Spearman and point-biserial correlation methods.
RESULTS: Our findings indicated a significant positive correlation between GPX1 immunoscore and high nucleolar grade (r = 0.80, p < 0.0001). In contrast, we observed a significant negative correlation between GPX3 immunoscore and high nucleolar grade (r = -0.77, p < 0.0001). We did not find statistically significant correlations between GPX1 expression and age, sex, tumor localization, or tumor size (p > 0.05), nor with capsular infiltration and invasion of the renal pelvis (p > 0.05). However, we did find statistically significant positive correlations between GPX1 expression and invasion of the renal vein (p = 0.038), perirenal fat (p = 0.043), and peripyelic fat (p = 0.015).
CONCLUSION: Our data demonstrate that GPX1 and GPX3 immunophenotypes could have a prognostic role for ccRCC, particularly in relation to nucleolar grade. This study has limitations because of the small sample size; however, it underscores the necessity for further research in larger, prospective studies. These studies should more thoroughly examine the associations between GPX1 and GPX3 and clinicopathological parameters, and validate them as potential novel prognostic biomarkers.
METHODS: We investigated the relationship between GPX1 and GPX3 immunophenotypes and clinicopathological parameters in 32 surgical specimens of clear cell RCC (ccRCC) with nucleolar grade 1-4 (WHO/ISUP grading). We evaluated the GPX1 and GPX3 immunophenotypes and assigned a histological immunoscore for each marker. For analysis, we used Spearman and point-biserial correlation methods.
RESULTS: Our findings indicated a significant positive correlation between GPX1 immunoscore and high nucleolar grade (r = 0.80, p < 0.0001). In contrast, we observed a significant negative correlation between GPX3 immunoscore and high nucleolar grade (r = -0.77, p < 0.0001). We did not find statistically significant correlations between GPX1 expression and age, sex, tumor localization, or tumor size (p > 0.05), nor with capsular infiltration and invasion of the renal pelvis (p > 0.05). However, we did find statistically significant positive correlations between GPX1 expression and invasion of the renal vein (p = 0.038), perirenal fat (p = 0.043), and peripyelic fat (p = 0.015).
CONCLUSION: Our data demonstrate that GPX1 and GPX3 immunophenotypes could have a prognostic role for ccRCC, particularly in relation to nucleolar grade. This study has limitations because of the small sample size; however, it underscores the necessity for further research in larger, prospective studies. These studies should more thoroughly examine the associations between GPX1 and GPX3 and clinicopathological parameters, and validate them as potential novel prognostic biomarkers.